Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma-Reference-Cited by-同舟云学术

Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma

Published:2023-12 Issue: Volume:142 Page:42-50
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Tekin Burak^ORCID,Cheville John C.,Herrera Hernandez Loren,Negron Vivian,Smith Carin Y.,Jenkins Sarah M.,Dasari Surendra,Enninga Elizabeth Ann L.,Norgan Andrew P.,Menon Santosh,Cubilla Antonio L.,Whaley Rumeal D.,Jimenez Rafael E.,Thompson R. Houston,Leibovich Bradley C.,Karnes R. Jeffrey,Boorjian Stephen A.,Pagliaro Lance C.,Erickson Lori A.,Guo Ruifeng,Gupta Sounak^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: a population-based study;Zhan;Cancer Med,2022

2. Global pattern and trends in penile cancer incidence: population-based study;Fu;JMIR Public Health Surveill,2022

3. Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: a study of 134 patients;Lobo;Am J Clin Pathol,2023

4. Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status;Ottenhof;J Urol,2017

5. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches;Udager;Ann Oncol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-based Therapies for Penile Cancer;Urologic Clinics of North America;2024-08

2. Overview of Systemic Therapies in Penile Cancer;Urologic Clinics of North America;2024-08

3. High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience;Human Pathology;2024-08

4. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer;Urologic Clinics of North America;2024-08

5. Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma;BJU International;2024-06-19